What is the recommended treatment for trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Trichomoniasis

Recommended First-Line Treatment

Metronidazole 500 mg orally twice daily for 7 days is the preferred treatment regimen for trichomoniasis, achieving cure rates of 90-95%. 1, 2

This multi-day regimen is superior to single-dose therapy based on the most recent high-quality evidence. A 2018 randomized controlled trial of 623 women demonstrated that the 7-day regimen resulted in significantly fewer treatment failures compared to single-dose therapy (11% vs 19% failure rate, p<0.0001). 3

Alternative Regimens

  • Single-dose option: Metronidazole 2 g orally as a single dose can be used, particularly for males or when adherence to multi-day therapy is uncertain, though it has lower efficacy 4, 5
  • Tinidazole: 2 g orally as a single dose is FDA-approved and demonstrates equivalent efficacy to single-dose metronidazole 6, 7
  • Secnidazole: 2 g orally as a single dose is newly FDA-approved with favorable pharmacokinetics including longer half-life 8

Critical Management Principles

Partner Treatment (Essential to Prevent Reinfection)

  • All sexual partners must be treated simultaneously 1, 2, 5
  • Patients must abstain from sexual activity until both partners complete treatment and are asymptomatic 1, 2
  • Failure to treat partners is the most common cause of recurrent infection 2
  • Treat asymptomatic male partners even with negative cultures, as the organism is difficult to isolate from male carriers 5

Alcohol Avoidance

  • Patients must avoid alcohol during treatment and for at least 24 hours after completing metronidazole therapy 4
  • Metronidazole causes a disulfiram-like reaction with alcohol (nausea, vomiting, flushing, headache, abdominal cramps) 4

Special Populations

Pregnancy

  • Metronidazole is contraindicated in the first trimester 1, 2
  • After the first trimester: Use metronidazole 2 g orally as a single dose 1, 2
  • Treatment is important as trichomoniasis is associated with premature rupture of membranes and preterm delivery 1

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative individuals 1, 2, 4

Metronidazole Allergy

  • Effective alternatives are limited 1
  • Patients with immediate-type allergy may require desensitization 1, 4

Treatment Failure Algorithm

First failure: Re-treat with metronidazole 500 mg twice daily for 7 days 1, 2, 4

Second failure: Administer metronidazole 2 g once daily for 3-5 days 1, 2, 4

Continued failure: After excluding reinfection, consult an infectious disease specialist 1, 4

Follow-Up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment 1, 2, 4
  • Re-evaluate only if symptoms persist, considering reinfection or resistant infection 2, 4

Critical Pitfall to Avoid

Never use topical metronidazole gel for trichomoniasis 2, 4

  • Topical metronidazole has efficacy <50% for trichomoniasis 2, 4
  • It fails to achieve therapeutic levels in the urethra and perivaginal glands 2
  • This is a common error that leads to treatment failure 2

References

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single dose treatment of trichomoniasis.

The Journal of international medical research, 1982

Research

Secnidazole: a treatment for trichomoniasis in adolescents and adults.

Expert review of anti-infective therapy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.